...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Great Presetation today
3
Oct 17, 2017 03:14PM
3
bfw
Oct 17, 2017 07:16PM
4
Oct 18, 2017 06:20AM
5
Oct 18, 2017 02:17PM
4
Oct 18, 2017 04:27PM
4
Oct 18, 2017 06:11PM
3
Oct 19, 2017 09:40AM
5
Oct 19, 2017 10:45AM

....Yes someone could invest in a 100% owned subsidiary, the only thing that changes is the subsidiary is no longer 100% owned.  That being said dilution then only occurs at the subsidiary level....

That makes sense.  Eastern has been buying shares of ZenEp, not ZCC. So I assume if ZenEp were sold, Eastern would get more than 1/3 of the proceeds off the top.  The rest would go to ZCC to be (possibly, hopefully) distributed amongst the commoners.

Zenith Epigenetics Closes US$24.6 Million Private Placement
May 16, 2016

CALGARY, May 16, 2016 /CNW/ - Zenith Epigenetics Corp. ("Zenith" or the "Company") today....Eastern holds 47,760,500 common shares of Zenith, representing approximately 38.6 percent of Zenith's issued and outstanding common shares....

4
Oct 19, 2017 07:22PM
2
Oct 20, 2017 02:04AM
3
Oct 20, 2017 10:35AM
2
Oct 21, 2017 11:36AM
3
Oct 23, 2017 12:27PM
3
Oct 24, 2017 02:27AM
4
Oct 24, 2017 01:39PM
Share
New Message
Please login to post a reply